Stella Diagnostics (Stella Diagnostics) Additional Paid-In Capital : $206.83 Mil(As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Additional Paid-In Capital?

Stella Diagnostics's quarterly additional paid-in capital stayed the same from . 20 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($206.83 Mil).

Stella Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for Stella Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Additional Paid-In Capital Chart

Stella Diagnostics Annual Data

Trend

Additional Paid-In Capital

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Additional Paid-In Capital	-	206.83

Stella Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Stella Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.